Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for Autism Behavioral Symptoms (RUPP Study)
NCT00005014Phase 3Completed
- Sponsor
- National Institute of Mental Health
- Start
- Oct 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risperidone in Autism Spectrum Disorder (ASD), sponsored by National Institute of Mental Health. Started Oct 1997; status: completed.
02
Drugs
risperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00005014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005014.